{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T20:46:37Z","timestamp":1781383597513,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019274","name":"National Institute of Mental Health and Neurosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH127323\\u201302"],"award-info":[{"award-number":["R01MH127323\\u201302"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["620229"],"award-info":[{"award-number":["620229"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007688","name":"American University of Beirut","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019603","name":"American University of Beirut Faculty of Medicine","doi-asserted-by":"publisher","award":["20046"],"award-info":[{"award-number":["20046"]}],"id":[{"id":"10.13039\/100019603","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ibneur.2025.06.005","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:22:15Z","timestamp":1751023335000},"page":"223-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease"],"prefix":"10.1016","volume":"19","author":[{"given":"Fatima","family":"Bilal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihane","family":"Soueid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Makhoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Hamze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"El-Bazzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Makoukji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-0079","authenticated-orcid":false,"given":"Rose-Mary","family":"Boustany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib1","first-page":"105","article-title":"Neurological progress. The neuronal ceroid lipofuscinoses: a review","volume":"145","author":"Boustany","year":"1989","journal-title":"Rev. Neurol. (Paris"},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ajmg.1320420421","article-title":"Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types","volume":"42","author":"Boustany","year":"1992","journal-title":"Am. J. Med Genet"},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00710257","article-title":"Seizures, depression and dementia in teenagers with Batten disease","volume":"16","author":"Boustany","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","article-title":"The neuronal ceroid-lipofuscinoses","volume":"62","author":"Haltia","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim Biophys. Acta"},{"issue":"9","key":"10.1016\/j.ibneur.2025.06.005_bib6","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for Batten disease: current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"1-3","key":"10.1016\/j.ibneur.2025.06.005_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0014-5793(03)00284-9","article-title":"Membrane topology of CLN3, the protein underlying Batten disease","volume":"541","author":"Mao","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ibneur.2025.06.005_bib9","unstructured":"Isolation of a novel gene underlying Batten disease, 1995. CLN3. The international batten disease consortiumCell826949957."},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1086\/514846","article-title":"Spectrum of mutations in the Batten disease gene, CLN3","volume":"61","author":"Munroe","year":"1997","journal-title":"Am. J. Hum. Genet"},{"issue":"10 Pt B","key":"10.1016\/j.ibneur.2025.06.005_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1203\/01.PDR.0000136152.54638.95","article-title":"A galactosylceramide binding domain is involved in trafficking of CLN3 from golgi to rafts via recycling endosomes","volume":"56","author":"Persaud-Sawin","year":"2004","journal-title":"Pedia Res"},{"issue":"6","key":"10.1016\/j.ibneur.2025.06.005_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1203\/PDR.0b013e31816fdc17","article-title":"CLN3p impacts galactosylceramide transport, raft morphology, and lipid content","volume":"63","author":"Rusyn","year":"2008","journal-title":"Pedia Res"},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/clp.11.70","article-title":"The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-golgi trafficking","volume":"7","author":"Cotman","year":"2012","journal-title":"Clin. Lipido"},{"issue":"7929","key":"10.1016\/j.ibneur.2025.06.005_bib15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41586-022-05221-y","article-title":"CLN3 is required for the clearance of glycerophosphodiesters from lysosomes","volume":"609","author":"Laqtom","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1471-4159.1996.67020677.x","article-title":"Apoptosis as the mechanism of neurodegeneration in Batten's disease","volume":"67","author":"Lane","year":"1996","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10143","article-title":"Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons","volume":"51","author":"Dhar","year":"2002","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-2007-973664","article-title":"Upregulation of Bcl-2 and elevation of ceramide in Batten disease","volume":"28","author":"Puranam","year":"1997","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s10495-005-0733-6","article-title":"Cell death pathways in juvenile Batten disease","volume":"10","author":"Persaud-Sawin","year":"2005","journal-title":"Apoptosis"},{"issue":"18","key":"10.1016\/j.ibneur.2025.06.005_bib20","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/hmg\/11.18.2129","article-title":"Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis","volume":"11","author":"Persaud-Sawin","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ibneur.2025.06.005_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2015.00215","article-title":"Association between CLN3 (neuronal ceroid lipofuscinosis, CLN3 Type) gene expression and clinical characteristics of breast cancer patients","volume":"5","author":"Makoukji","year":"2015","journal-title":"Front Oncol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib22","first-page":"801","article-title":"The CLN3 gene is a novel molecular target for cancer drug discovery","volume":"62","author":"Rylova","year":"2002","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.gene.2013.02.022","article-title":"Cell cycle arrest in Batten disease lymphoblast cells","volume":"519","author":"Kang","year":"2013","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopha.2013.12.010","article-title":"Effect of CLN3 silencing by RNA interference on the proliferation and apoptosis of human colorectal cancer cells","volume":"68","author":"Zhu","year":"2014","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ibneur.2025.06.005_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.ibneur.2025.06.005_bib28","doi-asserted-by":"crossref","first-page":"28706","DOI":"10.1074\/jbc.M203668200","article-title":"Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization","volume":"277","author":"Fujita","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6541","key":"10.1016\/j.ibneur.2025.06.005_bib29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/376599a0","article-title":"Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction","volume":"376","author":"Burgering","year":"1995","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ibneur.2025.06.005_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nchembio.103","article-title":"Raft nanodomains contribute to Akt\/PKB plasma membrane recruitment and activation","volume":"4","author":"Lasserre","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.ibneur.2025.06.005_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuro.2010.08.001","article-title":"Differential regulation of AKT, MAPK and GSK3beta during C2-ceramide-induced neuronal death","volume":"31","author":"Arboleda","year":"2010","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib33","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.170069","article-title":"Sphingolipids: membrane microdomains in brain development, function and neurological diseases","volume":"7","author":"Olsen","year":"2017","journal-title":"Open Biol."},{"key":"10.1016\/j.ibneur.2025.06.005_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med Biol."},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/mgme.1999.2834","article-title":"CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide","volume":"66","author":"Puranam","year":"1999","journal-title":"Mol. Genet Metab."},{"key":"10.1016\/j.ibneur.2025.06.005_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fneur.2019.00128","article-title":"Developmental comparison of ceramide in wild-type and Cln3 (\u0394ex7\/8) mouse brains and sera","volume":"10","author":"El-Sitt","year":"2019","journal-title":"Front Neurol."},{"issue":"18","key":"10.1016\/j.ibneur.2025.06.005_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810648","article-title":"Ceramide metabolism regulated by sphingomyelin synthase 2 is associated with acquisition of chemoresistance via exosomes in human leukemia cells","volume":"23","author":"Taniguchi","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.bbalip.2013.12.003","article-title":"The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders","volume":"1841","author":"Taniguchi","year":"2014","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.ibneur.2025.06.005_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuropharm.2018.02.023","article-title":"Pramipexole and fingolimod exert neuroprotection in a mouse model of parkinson's disease by activation of sphingosine kinase 1 and Akt kinase","volume":"135","author":"Motyl","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2025.06.005_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.suronc.2018.12.003","article-title":"Overexpression of CLN3 contributes to tumour progression and predicts poor prognosis in hepatocellular carcinoma","volume":"28","author":"Xu","year":"2019","journal-title":"Surg. Oncol."},{"issue":"10","key":"10.1016\/j.ibneur.2025.06.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165883","article-title":"Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium","volume":"1866","author":"Zhong","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ibneur.2025.06.005_bib44","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib46","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1471-2105-13-S2-S11","article-title":"Fold change and p-value cutoffs significantly alter microarray interpretations","volume":"13","author":"Dalman","year":"2012","journal-title":"BMC Bioinforma."},{"key":"10.1016\/j.ibneur.2025.06.005_bib47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4939-6780-3_19","article-title":"Method to measure sphingomyelin synthase activity changes in response to CD95L","volume":"1557","author":"Bilal","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1471-4159.2000.0750991.x","article-title":"Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells","volume":"75","author":"Encinas","year":"2000","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.ibneur.2025.06.005_bib49","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5685-08.2009","article-title":"Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice","volume":"29","author":"Zhou","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2025.06.005_bib50","first-page":"281","article-title":"AKT-independent PI3-K signaling in cancer - emerging role for SGK3","volume":"5","author":"Bruhn","year":"2013","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abd.2021.12.005","article-title":"Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K\/AKT\/mTOR pathway","volume":"98","author":"Chen","year":"2023","journal-title":"Bras. Dermatol."},{"issue":"11","key":"10.1016\/j.ibneur.2025.06.005_bib52","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1002\/ijc.33054","article-title":"The role of CDK6 in cancer","volume":"147","author":"Nebenfuehr","year":"2020","journal-title":"Int J. Cancer"},{"issue":"53","key":"10.1016\/j.ibneur.2025.06.005_bib53","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1523\/JNEUROSCI.3928-08.2008","article-title":"RTP801 is induced in parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation\/activation","volume":"28","author":"Malagelada","year":"2008","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in parkinson's disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.ibneur.2025.06.005_bib55","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","article-title":"Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease","volume":"26","author":"Xu","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.ibneur.2025.06.005_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1326-5-49","article-title":"NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration","volume":"5","author":"Kwak","year":"2010","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.ibneur.2025.06.005_bib57","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jnr.22057","article-title":"Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons","volume":"87","author":"Chen","year":"2009","journal-title":"J. Neurosci. Res"},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","article-title":"Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology","volume":"93","author":"Griffin","year":"2005","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib59","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbadis.2018.11.011","article-title":"Neuronal ceroid lipofuscinosis related ER membrane protein CLN8 regulates PP2A activity and ceramide levels","volume":"1865","author":"Adhikari","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"4","key":"10.1016\/j.ibneur.2025.06.005_bib60","first-page":"155","article-title":"Role of PI3K\/Akt\/GSK-3 pathway in emesis and potential new antiemetics","volume":"1","author":"Zhong","year":"2020","journal-title":"J. Cell Signal"},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104649","article-title":"The Batten disease protein CLN3 is important for stress granules dynamics and translational activity","volume":"299","author":"Relton","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/bjc.2011.241","article-title":"Oncogenic AKTivation of translation as a therapeutic target","volume":"105","author":"Hsieh","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"50","key":"10.1016\/j.ibneur.2025.06.005_bib63","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1038\/sj.onc.1209098","article-title":"The Akt of translational control","volume":"24","author":"Ruggero","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1474-9728.2003.00042.x","article-title":"Increased p27, an essential component of cell cycle control, in Alzheimer's disease","volume":"2","author":"Ogawa","year":"2003","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib65","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.3892\/mmr.2015.4339","article-title":"Downregulated microRNA-222 is correlated with increased p27Kip1 expression in a double transgenic mouse model of Alzheimer's disease","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"1","key":"10.1016\/j.ibneur.2025.06.005_bib66","first-page":"299","article-title":"Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury","volume":"20","author":"Chong","year":"2005","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ibneur.2025.06.005_bib67","article-title":"Autophagy in the neuronal ceroid lipofuscinoses (Batten disease). Front","volume":"10","author":"Kim","year":"2022","journal-title":"Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.ibneur.2025.06.005_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091311","article-title":"The multiple roles of sphingomyelin in parkinson's disease","volume":"11","author":"Signorelli","year":"2021","journal-title":"Biomolecules"},{"issue":"13","key":"10.1016\/j.ibneur.2025.06.005_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22137065","article-title":"The glucosylceramide synthase inhibitor PDMP causes lysosomal lipid accumulation and mTOR inactivation","volume":"22","author":"Hartwig","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ibneur.2025.06.005_bib70","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","article-title":"Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice","volume":"32","author":"Li","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib71","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3233\/JAD-2011-111202","article-title":"Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases","volume":"29","author":"Filippov","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib72","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1194\/jlr.TR119000427","article-title":"Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases","volume":"61","author":"Grassi","year":"2020","journal-title":"J. Lipid Res"},{"issue":"41","key":"10.1016\/j.ibneur.2025.06.005_bib73","doi-asserted-by":"crossref","first-page":"36053","DOI":"10.1074\/jbc.M111.228593","article-title":"Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation","volume":"286","author":"Shakor","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ibneur.2025.06.005_bib74","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1074\/jbc.M702423200","article-title":"Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human hela cells*","volume":"282","author":"Tafesse","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ibneur.2025.06.005_bib75","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cbin.10941","article-title":"Sphingomyelin in microdomains of the plasma membrane regulates amino acid-stimulated mTOR signal activation","volume":"42","author":"Zama","year":"2018","journal-title":"Cell Biol. Int"},{"issue":"3","key":"10.1016\/j.ibneur.2025.06.005_bib76","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s12035-014-8829-z","article-title":"Sphingomyelin synthase 1 regulates neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling","volume":"51","author":"Wesley","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ibneur.2025.06.005_bib77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.25573","article-title":"Exogenous galactosylceramide as potential treatment for CLN3 Disease","volume":"86","author":"El-Sitt","year":"2019","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ibneur.2025.06.005_bib78","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.24228","article-title":"Ceramide center stage in progressive myoclonus epilepsies","volume":"76","author":"Boustany","year":"2014","journal-title":"Ann. Neurol."}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667242125000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T04:18:54Z","timestamp":1766031534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667242125000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":78,"alternative-id":["S2667242125000880"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.06.005","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of AKT-mediated p27Kip1 phosphorylation with shift to sphingomyelin synthesis in CLN3 disease","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}